1. A Randomized Phase II Study of Carboplatin With Weekly or Every-3-Week Nanoparticle Albumin-Bound Paclitaxel (Abraxane) in Patients With Extensive-Stage Small Cell Lung Cancer. (23rd January 2015) Authors: Grilley-Olson, Juneko E.; Keedy, Vicki L.; Sandler, Alan; Moore, Dominic T.; Socinski, Mark A.; Stinchcombe, Thomas E. Journal: Oncologist Issue: Volume 20:Number 2(2015) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Randomized Phase II Study of Carboplatin With Weekly or Every‐3‐Week Nanoparticle Albumin‐Bound Paclitaxel (Abraxane) in Patients With Extensive‐Stage Small Cell Lung Cancer. (23rd January 2015) Authors: Grilley‐Olson, Juneko E.; Keedy, Vicki L.; Sandler, Alan; Moore, Dominic T.; Socinski, Mark A.; Stinchcombe, Thomas E. Journal: Oncologist Issue: Volume 20:Number 2(2015) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial. Issue 7 (July 2019) Authors: West, Howard; McCleod, Michael; Hussein, Maen; Morabito, Alessandro; Rittmeyer, Achim; Conter, Henry J; Kopp, Hans-Georg; Daniel, Davey; McCune, Steven; Mekhail, Tarek; Zer, Alona; Reinmuth, Niels; Sadiq, Ahad; Sandler, Alan; Lin, Wei; Ochi Lohmann, Tania; Archer, Venice; Wang, Lijia; Kowanetz, M... Journal: Lancet oncology Issue: Volume 20:Issue 7(2019) Page Start: 924 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study. (February 2019) Authors: Gadgeel, Shirish M.; Lukas, Rimas V.; Goldschmidt, Jerome; Conkling, Paul; Park, Keunchil; Cortinovis, Diego; de Marinis, Filippo; Rittmeyer, Achim; Patel, Jyoti D.; von Pawel, Joachim; O'Hear, Carol; Lai, Catherine; Hu, Sylvia; Ballinger, Marcus; Sandler, Alan; Gandhi, Mayank; Fehrenbacher, Lou Journal: Lung cancer Issue: Volume 128(2019) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial. Issue 10030 (30th April 2016) Authors: Fehrenbacher, Louis; Spira, Alexander; Ballinger, Marcus; Kowanetz, Marcin; Vansteenkiste, Johan; Mazieres, Julien; Park, Keunchil; Smith, David; Artal-Cortes, Angel; Lewanski, Conrad; Braiteh, Fadi; Waterkamp, Daniel; He, Pei; Zou, Wei; Chen, Daniel S; Yi, Jing; Sandler, Alan; Rittmeyer, Achim Journal: Lancet Issue: Volume 387:Issue 10030(2016) Page Start: 1837 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. Issue 10066 (21st January 2017) Authors: Rittmeyer, Achim; Barlesi, Fabrice; Waterkamp, Daniel; Park, Keunchil; Ciardiello, Fortunato; von Pawel, Joachim; Gadgeel, Shirish M; Hida, Toyoaki; Kowalski, Dariusz M; Dols, Manuel Cobo; Cortinovis, Diego L; Leach, Joseph; Polikoff, Jonathan; Barrios, Carlos; Kabbinavar, Fairooz; Frontera, Osva... Journal: Lancet Issue: Volume 389:Issue 10066(2017) Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Modeling and simulation of maintenance treatment in first-line non-small cell lung cancer with external validation. Issue 1 (December 2016) Authors: Han, Kelong; Claret, Laurent; Sandler, Alan; Das, Asha; Jin, Jin; Bruno, Rene Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prospects and progress of atezolizumab in non-small cell lung cancer. (3rd June 2017) Authors: Vansteenkiste, Johan; Wauters, Els; Park, Keunchil; Rittmeyer, Achim; Sandler, Alan; Spira, Alexander Journal: Expert opinion on biological therapy Issue: Volume 17:Number 6(2017:Jun.) Page Start: 781 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Recent progress in therapeutic antibodies for cancer immunotherapy. (June 2018) Authors: Lee, Anthony; Sun, Shawn; Sandler, Alan; Hoang, Tien Journal: Current opinion in chemical biology Issue: Volume 44(2018) Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety and clinical activity of atezolizumab monotherapy in metastatic non-small-cell lung cancer: final results from a phase I study. (September 2018) Authors: Horn, Leora; Gettinger, Scott N.; Gordon, Michael S.; Herbst, Roy S.; Gandhi, Leena; Felip, Enriqueta; Sequist, Lecia V.; Spigel, David R.; Antonia, Scott J.; Balmanoukian, Ani; Cassier, Philippe A.; Liu, Bo; Kowanetz, Marcin; O'Hear, Carol; Fassò, Marcella; Grossman, William; Sandler, Alan; Sori... Journal: European journal of cancer Issue: Volume 101(2018) Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗